Navigation Links
National study will look at German-made heart pump for children needing heart transplants

HOUSTON Jan.18, 2008 --Texas Childrens Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD).

Charles D. Fraser, Jr., MD, chief of pediatric and congenital heart surgery at Texas Childrens and professor, Michael E. DeBakey Department of Surgery at Baylor College of Medicine, will serve as the National Principal Investigator for the Investigational Device Exemption prospective study. As NPI, Fraser will work in cooperation with 10 U. S. hospitals and two Canadian hospitals, in collecting and reporting data to the United States Food and Drug Administration on the safety and probable benefit of the pediatric heart pump. At the studys conclusion, Berlin Heart, Inc. will present those data to the FDA for consideration of approval of the EXCOR Pediatric VAD for use in the U.S.

The Berlin Heart holds a lot of promise for infants and children whose hearts are failing, said Fraser. Its extremely gratifying to be part of such a collaborative study involving the FDA and the other leading heart centers around the nation in exchanging information that will ultimately benefit many pediatric heart patients.

The Berlin Heart EXCOR Pediatric VAD, which comes in graduated sizes to fit a pediatric population from newborns to teens, is the only pediatric heart pump that provides medium-to-long-term mechanical circulatory support for infants and children awaiting heart transplantations. The device has been approved in Germany and Europe since 1992, but does not have FDA approval for use in the U. S.

The Berlin Heart is especially attractive as an option for circulatory support in babies and small children awaiting heart transplantation, said Fraser. A particular advantage is that children can get up, walk around and be kids again while they are recovering and waiting for a donor heart.

Along with Texas Children's Hospital, 11 hospitals will participate in the study: Arkansas Childrens Hospital, Little Rock; Boston Childrens Hospital; Childrens Hospital of Wisconsin in Milwaukee; Riley Childrens Hospital, Indianapolis; Mott Children Hospital, Ann Arbor; Lucille Packard Childrens at Stanford; St. Louis Childrens Hospital; Seattle Childrens Hospital; and Childrens Hospital at the University of Alabama at Birmingham. Stollery Childrens Hospital in Edmonton, and the Hospital for Sick Kids in Toronto are participating in Canada.

In addition to the IDE study, Texas Childrens Heart Center has been named the first Berlin Heart Reference and Training Center in the United States offering support to hospitals not participating in the study who seek to use the Berlin Heart for the first time. Dr. David Morales, pediatric cardiovascular surgeon at Texas Childrens and assistant professor, Michael E. DeBakey Department of Surgery at Baylor College of Medicine, will direct a training team comprised of cardiac surgeons, cardiologists, perfusionists, operating room nurses, ICU nurses, research nurses and a designated Berlin Heart Fellow. The team will hold periodic training sessions at Texas Children's, and they will also travel to other hospitals to provide instruction on-site.

We are delighted to have the exerienced and dedicated team from Texas Childrens Heart Center as our first Reference and Training Center in the U.S., said Robert H. Halfmann, MD, director clinical science at Berlin Heart GmbH, Germany. We are also pleased to work with Dr. Fraser as the NPI for the EXCOR Pediatric IDE trial, which is of great importance to us.

Between 2000 and 2007, prior to FDA approval to begin the study, pediatric hospitals in the U. S. used the Berlin Heart under the FDAs emergency or compassionate use regulations. Each time a physician wanted to implant the Berlin Heart in a child dying of heart failure, a special appeal had to be made to the FDA for approval on a case-by-case basis. If approved, the Berlin Heart had to be flown from Germany while the child waited, possibly losing precious time. Also, under prior FDA regulations, the device could not be stored in the U.S., but had to be flown back to Germany if it was not used. Now with the IDE study in place, participating centers may keep the device on hand for easier access for their patients with failing hearts.


Physicians in Arizona implanted the first Berlin Heart in the U.S. in 2000. Later, a 4-month-old baby who received the Berlin Heart at Stanford University received high-profile media coverage in August, 2004. The coverage piqued interest in the Berlin Heart among pediatric hospitals around the country. Texas Childrens Heart Center implanted its first Berlin Heart on September 27, 2005 in one of the smallest babies to ever receive the device. Currently, Texas Childrens has implanted seven Berlin Hearts in infants and young children between the ages of two months to 12 years. Based on his experience with the device, Fraser, a strong advocate of small devices for babies, began working with representatives of the Berlin Heart company in submitting evidence to the FDA. On May 9, 2007, the FDA granted a Conditional Investigational Device Exemption approval that allowed for a multi-center study or clinical trial to be set up.


Contact: Carol Wittman
832-824-7243, ext. 5695
Texas Children's Hospital

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
(Date:11/27/2015)... Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... for use in Final Cut Pro X. With ProSidebar: Fasion, video editors can ... or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point Recovery, ... together on Thanksgiving Day to share the things that they are most grateful ... Point YouTube channel, patients displayed what they wrote on index cards, describing the ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology: